- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Non STEMI in Austria
Total 1214 results
-
AstraZenecaApproved for marketingNon Small Cell Lung Cancer (NSCLC)Taiwan, Thailand, Turkey, Brazil, Philippines, Russian Federation, Romania, Austria, Hungary, Bulgaria, Latvia, India, Argentina, Australia, Estonia, Malaysia, Mexico, Singapore, South Africa
-
Peter MacCallum Cancer Centre, AustraliaNovartisActive, not recruitingMantle Cell Lymphoma RecurrentAustralia
-
Peter MacCallum Cancer Centre, AustraliaCompletedHodgkin Lymphoma | Lymphoma, T-Cell, Cutaneous | Lymphoma, T-Cell, PeripheralAustralia
-
Navire Pharma Inc., a BridgeBio companyAmgenRecruitingNon Small Cell Lung Cancer | Metastatic Solid Tumor | Solid Tumor, Adult | Metastatic NSCLCSpain, Australia, France, Denmark, Greece, Italy, Netherlands
-
CelgeneCompletedMelanoma | Lymphoma | Multiple Myeloma | Pancreatic Cancer | Non-Small Cell Lung CancerAustralia
-
OnxeoCompletedCutaneous T-cell LymphomaAustria, France, Germany, Switzerland
-
BeiGeneTerminatedNon Small Cell Lung CancerChina, Taiwan, Australia, United States
-
BeiGeneCompletedNot DeterminedAustralia, China
-
Hoffmann-La RocheCompletedB-cell Non-Hodgkin LymphomaUnited States, Spain, Korea, Republic of, France, Austria, Poland
-
Hoffmann-La RocheCompletedNon-Hodgkin Lymphoma, Follicular LymphomaUnited Kingdom, Belgium, United States, Australia, Canada, Germany
-
R-PharmCompletedAdvanced/Metastatic Non-Small Cell Lung CancerGermany, Korea, Republic of, Russian Federation, Taiwan, Australia, Italy, France, United States, Argentina, Spain
-
BeiGeneRecruitingRefractory Chronic Lymphocytic Leukemia | Refractory Non-Hodgkin Lymphoma | Relapsed Follicular Lymphoma | Refractory Small Lymphocytic Lymphoma | Refractory Follicular Lymphoma | Refractory Marginal Zone Lymphoma | Refractory Diffuse Large B-cell Lymphoma | Transformed Non-Hodgkin Lymphoma | Relapsed... and other conditionsChina, Australia
-
National Institute of Diabetes and Digestive and...CompletedDiabetes Mellitus, Non-Insulin-DependentUnited States
-
Eli Lilly and CompanyCompletedNon Small Cell Lung CancerMexico, Italy, Australia, Spain
-
NeoTX Therapeutics Ltd.Translational Drug DevelopmentCompleted
-
Peter MacCallum Cancer Centre, AustraliaActive, not recruiting
-
AbbVieGenentech, Inc.Active, not recruitingNon-Hodgkin's Lymphoma | Hematological Malignancies | Chronic Lymphoid Leukemia | CD20-Positive Lymphoid MalignanciesUnited States, Australia
-
Eli Lilly and CompanyCompletedNon-Small Cell Lung CancerTaiwan, Korea, Republic of, Brazil, China, Australia, Mexico
-
International Extranodal Lymphoma Study Group (IELSG)CompletedMarginal Zone B-cell LymphomaItaly, Switzerland, Austria
-
Klinikum FloridsdorfMedical University of Vienna; Klinik Favoriten; Salzkammergut Klinikum VöcklabruckCompletedThe Aim of This Study is to Determine the Influence of BMI and Lymph Node Status on OS in CRC Patients in the Long TermAustria
-
International Extranodal Lymphoma Study Group (IELSG)Active, not recruitingMarginal Zone LymphomaItaly, Switzerland, Austria
-
Olivia Newton-John Cancer Research InstituteAustin Health; Roche Products Pty Limited; Ballarat Health ServicesActive, not recruitingFollicular LymphomaAustralia
-
AstraZenecaDaiichi SankyoRecruitingNon-small Cell Lung CancerGermany, Taiwan, Australia, China, Korea, Republic of
-
Hoffmann-La RocheCompletedNon-Hodgkin's LymphomaFrance, Italy, Australia, Canada, Sweden, Switzerland
-
Olivia Newton-John Cancer Research InstituteBristol-Myers Squibb; Barwon Health; Austin Health; Eastern Health; Fiona Stanley... and other collaboratorsRecruitingFollicular Lymphoma Stage II | Follicular Lymphoma Stage III | Follicular Lymphoma Stage IVAustralia
-
IGM Biosciences, Inc.ADC Therapeutics S.A.Active, not recruitingFollicular Lymphoma | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Non-Hodgkin Lymphoma | DLBCLUnited States, Korea, Republic of, Spain, France, Australia, Czechia, Italy
-
Novartis PharmaceuticalsCompletedWell-differentiated Non-functional NET of Thoracic Origin | Well-differentiated Non-functional NET of Gastrointestinal Origin | Well-differentiated Non-functional NET of Pancreatic Origin | Poorly-differentiated Gastroenteropancreatic Neuroendocrine CarcinomaUnited States, Italy, Spain, Japan, Belgium, Netherlands, Germany, France, Canada, Austria, United Kingdom, Australia
-
TakedaActive, not recruitingRelapsed or Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)United States
-
Arcus Biosciences, Inc.Gilead SciencesActive, not recruitingLung Cancer | Non Small Cell Lung Cancer | Squamous Non Small Cell Lung Cancer | Nonsquamous Non Small Cell Lung CancerUnited States, Taiwan, Korea, Republic of, Australia, Singapore, Hong Kong, Canada
-
Bayside HealthCompletedNon-Hodgkin's Lymphoma | Hodgkin's DiseaseAustralia
-
Regeneron PharmaceuticalsCompletedRelapsed/Refractory Follicular LymphomaAustria, France, Germany, United Kingdom
-
Cellxpert Biotechnology Corp.Medigen Biotechnology CorporationCompletedCarcinoma, Non-Small-Cell LungAustralia
-
Boehringer IngelheimCompletedNon-alcoholic Steatohepatitis (NASH)United States, Spain, Korea, Republic of, United Kingdom, Australia, Canada, Singapore, Germany, Italy, Malaysia, China, France, Japan, Taiwan, Netherlands, Austria, Israel, New Zealand, Poland, Hong Kong, Belgium, Czechia, Greece, Hu... and more
-
Eucure (Beijing) Biopharma Co., LtdWithdrawnHCC | NSCLC Stage IV | NSCLC Stage IIIBChina, Australia, Taiwan, Armenia, Austria
-
Sana BiotechnologyRecruitingChronic Lymphocytic Leukemia | Non Hodgkin LymphomaUnited States, Australia
-
Axcella Health, IncRecruitingNon Alcoholic Steatohepatitis (NASH)United States, Canada, United Kingdom, Australia, France, Poland, Puerto Rico
-
Northern Sydney and Central Coast Area Health ServiceMerck KGaA, Darmstadt, GermanyUnknownNewly Diagnosed Non Methylated Glioblastoma Multiforme Grade 4Australia
-
Hoffmann-La RocheRecruitingLymphoma, Non-HodgkinUnited States, Denmark, Italy, France, Australia, United Kingdom
-
Novartis PharmaceuticalsCompletedNon-small Cell Lung Cancer | Anaplastic Lymphoma Kinase (ALK)Australia, Spain, Singapore, Italy, United States
-
Bristol-Myers SquibbCompletedNon-Squamous Cell Non-small Cell Lung CancerUnited States, Germany, Hong Kong, Spain, Australia, Mexico, Austria, France, Singapore, Switzerland, Canada, Poland, Argentina, Brazil, Chile, Czechia, Hungary, Italy, Norway, Peru, Romania, Russian Federation
-
Boehringer IngelheimApproved for marketingCarcinoma, Non-Small-Cell LungAustralia
-
Peter MacCallum Cancer Centre, AustraliaAbbVieNot yet recruitingRelapsed/Refractory Large B-cell LymphomaAustralia
-
Medical University of GrazCompletedPatch/Plaque Stage Mycosis FungoidesAustria
-
NorthSea Therapeutics B.V.Active, not recruitingNon Alcoholic Steatohepatitis (NASH)United States, Puerto Rico
-
The Touro College and University SystemUniversity of Vienna; Osato Research Institute; University of Mauritius; Mauritius... and other collaboratorsCompletedAssess the Effect of Green Tea on Diabetes | Assess the Effect of Fermented Papaya Pretration on Diabetes | Effects of Green Tea and FPP on C-reactive Proteins | Effects of Green Tea and FPP of Lipid Profiles in Diabetes | Effect of Green Tea and FPP on Atheroma FormationAustria, Mauritius, United States
-
CephalonCompletedNon-Hodgkin's LymphomaUnited States, Australia, Canada
-
Santen Inc.CompletedNon-Infectious Uveitis of the Posterior Segment of the EyeUnited States, France, Turkey, Italy, Austria, India
-
Bayside HealthCompletedNon-Hodgkin's Lymphoma | Hodgkin's DiseaseAustralia
-
iOMEDICO AGBeiGene Switzerland GmbHRecruitingFollicular Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Waldenström's MacroglobulinemiaGermany, Austria
-
Genentech, Inc.Roche Pharma AGCompletedNon-Small Cell Lung CancerAustralia, United States